LFSS 2024: new paybacks to penalise medical devices with a negative environmental impact
On December 4, 2023, the French National Assembly definitively adopted the Social Security Financing Bill (PLFSS) on final reading without voting. Article…
PLFSS 2024: a new reimbursement regime post early access
Early access makes it possible to finance treatments that are presumed to be innovative and often expensive. However, once this…
Contradictory procedure: what’s at stake in terms of market access?
Many decisions concerning the reimbursement of healthcare products must be preceded by a contradictory procedure. The aim of this procedure…
Mission Borne: toward a redefinition of conventional policy?
The Borne Mission[1] recommends reforming certain aspects of healthcare product pricing. It proposes, for example, that new factors be taken into…
Mission Borne: new pricing factors for health products?
After months of work and more than 170 hearings, the interministerial Borne Mission yesterday presented its conclusions to the Ministers…
Vaccination: extension of prescription rights
Until now, the right to prescribe vaccines was reserved for physicians and, under certain conditions, midwives. However, the latter's competence…